Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates

Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Rafael Harpaz, Ismael R. Ortega‐Sanchez, Jane F. Seward · 2008 · 1.3K citations

Vaccination, Vaccine Safety, Preventive Medicine +6

Prevalence of selected developmental disabilities in children 3-10 years of age: the Metropolitan Atlanta Developmental Disabilities Surveillance Program, 1991.

Coleen A. Boyle, Marshalyn Yeargin‐Allsopp, Nancy Doernberg et al. · PubMed · 1996 · 841 citations

The V-Antigen of <i>Yersinia</i> Forms a Distinct Structure at the Tip of Injectisome Needles

Catherine A. Mueller, Petr Brož, Shirley A. Müller et al. · Science · 2005 · 359 citations

Protein Secretion, Microbial Pathogens, Translocation Process +17

Yersinia V–Antigen Exploits Toll-like Receptor 2 and CD14 for Interleukin 10–mediated Immunosuppression

Andreas Sing, Dagmar Rost, Natalia Tvardovskaia et al. · The Journal of Experimental Medicine · 2002 · 329 citations · Full text

Innate Immune System, Immunology, Cd4 T Cell Responses +17

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

David G. Heath, G.W. Anderson, J. Matthew Mauro et al. · Vaccine · 1998 · 278 citations

Vaccination, Pneumonic Plague, Cross-protection +7